ELAB
Price
$5.09
Change
-$0.03 (-0.59%)
Updated
Dec 4, 12:00 PM (EDT)
Capitalization
3.81M
Intraday BUY SELL Signals
TGTX
Price
$31.52
Change
-$0.09 (-0.28%)
Updated
Dec 4, 04:40 PM (EDT)
Capitalization
5.02B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAB vs TGTX

Header iconELAB vs TGTX Comparison
Open Charts ELAB vs TGTXBanner chart's image
PMGC Holdings
Price$5.09
Change-$0.03 (-0.59%)
Volume$486
Capitalization3.81M
TG Therapeutics
Price$31.52
Change-$0.09 (-0.28%)
Volume$500
Capitalization5.02B
ELAB vs TGTX Comparison Chart in %
View a ticker or compare two or three
VS
ELAB vs. TGTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAB is a Hold and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ELAB: $5.12 vs. TGTX: $31.61)
Brand notoriety: ELAB and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELAB: 3% vs. TGTX: 84%
Market capitalization -- ELAB: $3.81M vs. TGTX: $5.02B
ELAB [@Biotechnology] is valued at $3.81M. TGTX’s [@Biotechnology] market capitalization is $5.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAB’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • ELAB’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TGTX is a better buy in the long-term than ELAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAB’s TA Score shows that 5 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • ELAB’s TA Score: 5 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ELAB is a better buy in the short-term than TGTX.

Price Growth

ELAB (@Biotechnology) experienced а -3.03% price change this week, while TGTX (@Biotechnology) price change was -5.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.75%. For the same industry, the average monthly price growth was +5.41%, and the average quarterly price growth was +55.63%.

Reported Earning Dates

TGTX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.02B) has a higher market cap than ELAB($3.81M). TGTX has higher P/E ratio than ELAB: TGTX (11.41) vs ELAB (0.01). TGTX YTD gains are higher at: 5.017 vs. ELAB (-90.695). TGTX has higher annual earnings (EBITDA): 97.6M vs. ELAB (-4.37M). TGTX has more cash in the bank: 252M vs. ELAB (6.31M). ELAB has less debt than TGTX: ELAB (103K) vs TGTX (254M). TGTX has higher revenues than ELAB: TGTX (454M) vs ELAB (0).
ELABTGTXELAB / TGTX
Capitalization3.81M5.02B0%
EBITDA-4.37M97.6M-4%
Gain YTD-90.6955.017-1,808%
P/E Ratio0.0111.410%
Revenue0454M-
Total Cash6.31M252M3%
Total Debt103K254M0%
FUNDAMENTALS RATINGS
TGTX: Fundamental Ratings
TGTX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
35
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELABTGTX
RSI
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
87%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 7 days ago
85%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
80%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 22 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
73%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ELAB
Daily Signal:
Gain/Loss:
TGTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBFH32.820.29
+0.89%
Gbank Financial Holdings Inc
NXT86.59-0.85
-0.97%
Nextracker
ZLAB19.51-0.37
-1.86%
Zai Lab Limited
TVGN0.39-0.02
-4.53%
Tevogen Bio Holdings
LGHL6.46-0.78
-10.77%
Lion Group Holding Ltd.

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and LXRX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and LXRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-0.94%
LXRX - ELAB
25%
Poorly correlated
-1.10%
MTNB - ELAB
25%
Poorly correlated
+3.77%
EDSA - ELAB
24%
Poorly correlated
+1.17%
LTRN - ELAB
21%
Poorly correlated
-0.28%
TGTX - ELAB
21%
Poorly correlated
-3.32%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with KRYS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+3.20%
KRYS - TGTX
42%
Loosely correlated
+1.12%
PTCT - TGTX
37%
Loosely correlated
-3.48%
ARRY - TGTX
36%
Loosely correlated
+4.28%
CLLS - TGTX
36%
Loosely correlated
-1.06%
AXON - TGTX
36%
Loosely correlated
+1.08%
More